US · Healthcare · Medical Instruments & Supplies
EPS came in at 1.97 against a street estimate of 1.75 — a beat of 12.6%.
Analysts rate ICU Medical Inc a buy (5 buy, 1 hold, 0 sell out of 6) with an average price target of $176.62.
| Fund | Stake |
|---|---|
| BlackRock Inc | 14.44% |
| HHG PLC | 10.71% |
| Vanguard Portfolio Management, LLC | 5.75% |
| Fuller & Thaler Asset Management Inc | 4.88% |
| Vanguard Capital Management, LLC | 4.45% |
| Dimensional Fund Advisors, Inc. | 3.94% |
| State Street Corp | 3.87% |
| Schroder Investment Management Group | 2.81% |
| Document | Date |
|---|---|
| Charter / bylaws change · Q2 2026 | 2026-05-18 |
| Quarterly report · Q1 2026 | 2026-05-07 |
| Results announced · Q2 2026 | 2026-05-07 |
| Proxy statement · Q2 2026 | 2026-04-02 |
| Board / officer change · Q1 2026 | 2026-02-20 |
| Annual report FY2025 | 2026-02-19 |
| Results announced · Q1 2026 | 2026-02-19 |
| Quarterly report · Q3 2025 | 2025-11-06 |
Readable in the app.
Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for ICU Medical Inc — free to start.
Google PlayApp StoreData updated 2026-08-05.